Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) appointed Silvia Taylor Senior Vice President of Investor Relations, Public Relations, and Corporate Communications. Silvia, who holds an MBA from Columbia Business School, had been with MedImmune where she was Senior Director of Marketing, RSV Franchise and Senior Director of Marketing, Global Influenza Franchise. Read more in the Business Wire press release.



Comments